During the past decade, ALIAN s.r.o. conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 13 clinical trials were completed, i.e. on average, 56.5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 9 clinical trials were completed. i.e. 69.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ALIAN s.r.o." #1 sponsor was "Bayer" with 4 trials, followed by "Celgene" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Abivax S.A." with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ALIAN s.r.o." #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "ALIAN s.r.o." are "Ulcerative Colitis" (9 trials), "Coronary Artery Disease" (3 trials), "Crohn's Disease" (3 trials), "Atrial Fibrillation" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "ALIAN s.r.o." in a lesser frequency.

Most popular intervention types in "ALIAN s.r.o." are "Drug" (26 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Etrasimod" (4 trials), "GED-0301" (2 trials), "RPC1063" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "ALIAN s.r.o." are 28 trials for "All" genders.

Currently, there are NaN active trials in "ALIAN s.r.o.". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in ALIAN s.r.o., undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in ALIAN s.r.o., 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".